Although the authors did not directly assess vsiRNA production using a deep-sequencing approach in these cells, antiviral RNAi activity was suggested via a “dsRNA vaccination experiment” in which IFN-deficient cells were protected from virus infection by prior treatment with virus sequence-specific long dsRNA [21]. The gene discussed is IFNA1; the disease is viral infectious disease.